DEGREES
BTitle of Docent in surgery (experimental), University of Helsinki 28 Nov 2019
Specialist (board certification) in gastrointestinal surgery, University of Helsinki 20 Jun 2018
Doctor of Medical Sciences (PhD), University of Eastern Finland 30 Aug 2012
Licentiate of Medicine (MD), University of Eastern Finland 22 Dec 2010

CURRENT EMPLOYMENT
Associate Professor Faculty of Medicine and Medical Technology 1 Feb 2022– University of Tampere
Chief Physician, Gastroenterology and Alimentary tract surgery 1 Feb 2022–
GI surgeon Tampere University Hospital
Principal Investigator University of Helsinki, Applied Tumor Genomics 2019– Research Program and Helsinki University Hospital

PREVIOUS WORK EXPERIENC
Research fellow Dept. Surgical Oncology 1 Aug 2019 – 31 Jun 2021 Johns Hopkins University, Baltimore, MD, US
GI surgeon/res Department of Gastrointestinal Surgery 1 Jan 2016 – 31 Jan 2022 Helsinki University Hospital (7 mo postdoc research)
Resident Central Finland Central Hospital, Jyväskylä (total 47 months) 2012–2015 – Chief resident (26 mo), GI surgery 20 mo, research (4 mo)
Parental leaves (5 months) 2017–2021

RESEARCH FUNDING (appr. 5.8 M€)
Horizon Mission 2024-Cancer-01-03 (1,416,000 € /13.6 M€) 2025–2032
iCAN Flagship national expansion funding (626,000 €) 2024–2026
Sigrid Juselius Foundation 2-year funding (100,000 €) 2024–2026
Mary & Georg Ehrnrooth Foundation (50,000 €) 2024–2025
Pirha State Research funding (60,000 €) 2024–2025
Finnish Cancer Society funding (180,000 €) 2023–2026
TAYS Research Foundation funding (10,000€) 2023–2024
Pirha State Research funding (40,000 €) 2023–2024
iCAN Flagship subproject resources (990,000 €) 2023–2026
The Academy of Finland project funding / HUS (714,000 €) 2021–2025
Jane and Aatos Erkko Foundation funding (280,000€/1,173,000 €) 2021–2025 – Together with co-PIs P. Peltomäki, J-P. Mecklin and M. Nyström
HUS State Research Funding (VTR; 145,000 €) 2021–2024
iCAN Flagship subproject funding (330,000 €) 2021–2022
Sigrid Juselius Foundation 3-year funding (150,000 €) 2021–2024
Relander Foundation funding (45,000 €) 2021–2023
Finnish Cancer Society (150,000 €) 2021–2023
Emil Aaltonen’s Foundation funding (210,000 €) 2019–2023
Fellowship Grant, Sigrid Juselius Foundation (140,000 €) 2019–2021
Fellowship Grant, Instrumentarium Science Foundation (40,000 €) 2019–2021
Finnish Medical Foundation funding for research group starting (150,000 €) 2019–2021

RESEARCH OUTPUT 2010–2024
Total number of peer-reviewed publications: 103
– Mean/median impact factor (IF 2022): 11.1/6.4
– Median journal field quartile: 1
– Total JUFO points: 168
– Number of citations: 6143 (Google Scholar Dec 18th 2024)
– h-index: 37 / m-index: 2.84 / i10-index: 61 / h-index since 2019: 36
Other research items, authorships and media output related to research: 53
– TV, online, radio, podcast and newspaper interviews, guideline work, websites, letters, book chapters, preprints

RESEARCH SUPERVISION AND LEADERSHIP EXPERIENCE
10 PhD theses supervised, 1 completed
1 MSc thesis completed, 2 Bachelor’s theses completed
PhD Supervisory committees: 9
Research group leadership since 2018
Wet laboratory leadership since 2021
Postgraduate and postdoctoral supervision since 2017 onwards in Finland and US – At least 1 established independence (Dr. Jussi Nikkola)
Leadership experience in research, business and clinical medicine/surgery since 2001

TEACHING MERITS
Pedagogical training: 10 credits, University of Helsinki 2018
Evaluated good teaching skills for the Title of Docent, University of Helsinki 2019
Editor for MET Cancer Seminar Series, TUNI 2022–

AWARDS AND HONOURS
AACR 2023 Inaugural Cancer Prevention Research Award, Orlando, FL, US 2023
Meera Khan named lecture, InSiGHT 2022, New York, NY, US 2022
Eero Saksela Award, FCI Symposium 2022, Helsinki 2022
Young Scientist of the Year, Gastropäivät 2016, Helsinki, 2016
Finnish Digestive Surgeons

OTHER KEY ACADEMIC MERITS
Reviewer/Opponent/Editor
Reviewer for PhD theses: 2 (Uni Turku x 2) 2021–
Opponent for PhD dissertation: 2 (Uni Tartu x 2) 2022–
Reviewer for the JGW Patterson Foundation, UK 2023
Reviewer for the Dutch Cancer Society (KWF), funding applications 2018–2020

Reviewer for scientific journals: 72 verified reviews on Web of Science 2012–2024 Editorial board member for BJS Open 2022–
Section Editor for Scand J Surg (surgical oncology and colorectal surgery) 2024–
Associate Editor for Hereditary Cancer in Clinical Practice 2020–
Special Issue Editor for Frontiers in Oncology 2022
Special Issue Editor for Journal of Clinical Medicine 2021

SCIENTIFIC AND SOCIETAL IMPACT AND MEDICAL COMMUNITY SERVICE
Advisory roles in Lynsight Ltd, Orion Pharma Ltd, Nouscom Ltd, FICAN Mid and the Finnish Cancer Institute.
Leadership roles, e.g. on the boards of International Society for Inherited Gastrointestinal Tumors (InSiGHT), the Finnish Society of Surgery (SKY), the European Hereditary Tumour Group (EHTG), and the Surgery Development Foundation (KES), and significant roles in the Finnish Junior Doctors’ Association, The Finnish Medical Society Duodecim, and Finnish Medical Association.
Scientific roles, e.g. the Prospective Lynch Syndrome Database Scientific Committee, European Reference Network (ERN) Genturis, Ministry of Social Affairs and Welfare Rare diseases working group (Harvinaiset), and an Expert Working Group for the National Institute for Health and Welfare.
Media output: please see list of publications for reference on public and media appearance for societal impact.